120 related articles for article (PubMed ID: 32410514)
1. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients.
Kincius M; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
Aging Male; 2020 Dec; 23(5):1333-1338. PubMed ID: 32410514
[TBL] [Abstract][Full Text] [Related]
2. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
[TBL] [Abstract][Full Text] [Related]
3. Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer.
Linkeviciute-Ulinskiene D; Patasius A; Kincius M; Zabuliene L; Smailyte G
Scand J Urol; 2020 Oct; 54(5):401-407. PubMed ID: 32748714
[TBL] [Abstract][Full Text] [Related]
4. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
5. Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania.
Undzyte G; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Stukas R; Dulskas A; Smailyte G
Aging Male; 2020 Dec; 23(5):1241-1245. PubMed ID: 32342709
[TBL] [Abstract][Full Text] [Related]
6. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
7. Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
Azoulay L; Dell'Aniello S; Gagnon B; Pollak M; Suissa S
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):337-44. PubMed ID: 21148757
[TBL] [Abstract][Full Text] [Related]
8. Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer.
Raval AD; Mattes MD; Madhavan S; Pan X; Wei W; Sambamoorthi U
J Diabetes Res; 2016; 2016():2656814. PubMed ID: 27547763
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
10. Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study.
Chen CB; Eurich DT; Majumdar SR; Johnson JA
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):122-126. PubMed ID: 28071672
[TBL] [Abstract][Full Text] [Related]
11. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
12. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
13. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
14. Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus.
Chong RW; Vasudevan V; Zuber J; Solomon SS
Am J Med Sci; 2016 Apr; 351(4):416-9. PubMed ID: 27079349
[TBL] [Abstract][Full Text] [Related]
15. Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II Diabetes.
Wang CP; Lehman DM; Lam YF; Kuhn JG; Mahalingam D; Weitman S; Lorenzo C; Downs JR; Stuart EA; Hernandez J; Thompson IM; Ramirez AG
Cancer Prev Res (Phila); 2016 Oct; 9(10):779-787. PubMed ID: 27026681
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.
Kuo YJ; Sung FC; Hsieh PF; Chang HP; Wu KL; Wu HC
Cancer Med; 2019 May; 8(5):2514-2523. PubMed ID: 30968600
[TBL] [Abstract][Full Text] [Related]
17. Metformin increases cancer specific survival in colorectal cancer patients-National cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Cancer Epidemiol; 2019 Oct; 62():101587. PubMed ID: 31491730
[TBL] [Abstract][Full Text] [Related]
18. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
Tseng CH
Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
[TBL] [Abstract][Full Text] [Related]
19. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
20. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
Tseng CH
J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]